Immunotherapy named as the “Advance of the year”

The American Society of Clinical Oncology named immunotherapy as the “Advance of the year”. There were many exciting developments, as you can see from some of our previous posts. There have also been exciting trials with immune therapy in bladder cancer, Hodgkin disease, liver cancer and head and neck cancer. These are especially exciting because many of these cancers (bladder, liver cancer) do not have many other chemotherapy alternatives. Given all these advances, it is important to get cancer care from a clinic that specializes solely in chemotherapy and immunotherapy — as the side effects and treatment are completely different from normal chemotherapy. We communicate with our other specialty physicians at Brookwood too to help treat any complications optimally.